JP2023523155A5 - - Google Patents

Info

Publication number
JP2023523155A5
JP2023523155A5 JP2022560857A JP2022560857A JP2023523155A5 JP 2023523155 A5 JP2023523155 A5 JP 2023523155A5 JP 2022560857 A JP2022560857 A JP 2022560857A JP 2022560857 A JP2022560857 A JP 2022560857A JP 2023523155 A5 JP2023523155 A5 JP 2023523155A5
Authority
JP
Japan
Prior art keywords
once
days
pharmaceutical composition
group
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022560857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023523155A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000261 external-priority patent/WO2021214545A1/en
Publication of JP2023523155A publication Critical patent/JP2023523155A/ja
Publication of JP2023523155A5 publication Critical patent/JP2023523155A5/ja
Pending legal-status Critical Current

Links

JP2022560857A 2020-04-20 2021-04-20 慢性疼痛治療のためのカンナビジオール及び／又はテトラヒドロカンナビノールを含有する経皮製剤及び／又は局所製剤 Pending JP2023523155A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063012428P 2020-04-20 2020-04-20
US63/012,428 2020-04-20
PCT/IB2021/000261 WO2021214545A1 (en) 2020-04-20 2021-04-20 Transdermal and/or topical pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic pain

Publications (2)

Publication Number Publication Date
JP2023523155A JP2023523155A (ja) 2023-06-02
JP2023523155A5 true JP2023523155A5 (https=) 2024-05-23

Family

ID=78270322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560857A Pending JP2023523155A (ja) 2020-04-20 2021-04-20 慢性疼痛治療のためのカンナビジオール及び／又はテトラヒドロカンナビノールを含有する経皮製剤及び／又は局所製剤

Country Status (8)

Country Link
US (2) US20210346310A1 (https=)
EP (1) EP4110325A4 (https=)
JP (1) JP2023523155A (https=)
CN (1) CN115916184A (https=)
AU (1) AU2021259495A1 (https=)
CA (1) CA3178878A1 (https=)
MX (1) MX2022012415A (https=)
WO (1) WO2021214545A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4041209A4 (en) 2019-10-11 2024-01-24 Pike Therapeutics, Inc. TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF EPILEPTIC DISORDERS
CA3155181A1 (en) 2019-10-14 2021-04-22 Pike Therapeutics, Inc., 1219014 B.C. Ltd. Transdermal delivery of cannabidiol
US12121617B2 (en) 2019-10-14 2024-10-22 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
US12268699B2 (en) 2019-10-14 2025-04-08 Pike Therapeutics Inc. Transdermal delivery of tetrahydrocannabinol
WO2022003623A1 (en) * 2020-07-01 2022-01-06 Pike Therapeutics, Inc. Transdermal pharmaceutical formulations for the treatment of multiple sclerosis
CN117337174A (zh) * 2020-12-03 2024-01-02 长矛治疗股份有限公司 用于治疗癌症的包含cbd或thc的透皮药物制剂
AU2022257344A1 (en) * 2021-04-12 2023-10-26 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
CN117545478A (zh) * 2021-04-22 2024-02-09 长矛治疗股份有限公司 用于治疗慢性疼痛的透皮药物制剂
EP4366728A4 (en) * 2021-07-08 2025-05-14 Innocan Pharma Ltd. COMPOSITIONS FOR THE TREATMENT OF DIABETIC SYMPTOMS
WO2023012691A1 (en) * 2021-08-03 2023-02-09 Pike Therapeutics, Inc. Transdermal micro-dosing delivery of pharmaceutical agents
EP4426290A4 (en) * 2021-11-02 2025-10-08 Schedule 1 Therapeutics Inc USE OF CANNABINOID COMPOSITIONS TO TREAT PAIN ASSOCIATED WITH SMALL FIBER NEUROPATHY
EP4558135A1 (en) * 2022-07-21 2025-05-28 Pike Therapeutics Inc. Continuous delivery systems comprising a cannabinoid and medicinal uses thereof
US11826342B1 (en) * 2022-09-27 2023-11-28 Saaransh Mahna Cannabidiol formulation for alleviating pain and a method of manufacturing
CN118045221B (zh) * 2024-02-04 2024-07-19 广东云曌医疗科技有限公司 一种水凝胶敷料及其制备方法和应用
WO2026018119A1 (en) * 2024-07-16 2026-01-22 Pike Therapeutics Inc. Transdermal delivery of tetrahydrocannabinol

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2414933B (en) * 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
WO2008019146A2 (en) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Aqueous dronabinol formulations
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
CA2760460C (en) * 2009-04-28 2019-04-02 Alltranz Inc. Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same
EP2424568A1 (en) * 2009-04-29 2012-03-07 University Of Kentucky Research Foundation Cannabinoid-containing compositions and methods for their use
PT2473475T (pt) * 2009-08-31 2017-08-02 Zynerba Pharmaceuticals Inc Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas
AT509000B1 (de) * 2009-10-23 2012-12-15 Rausch Peter Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen
US9408802B1 (en) * 2012-03-22 2016-08-09 Prosolus, Inc. Seven day drug in adhesive transdermal delivery
US9095563B2 (en) * 2013-09-26 2015-08-04 Ronald D. Sekura Topical treatments incorporating Cannabis sp. derived botanical drug product
US20160022627A2 (en) * 2014-04-18 2016-01-28 Mary's Medicinals LLC Transdermal cannabinoid patch
US9375417B2 (en) * 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
CA2976004C (en) * 2015-02-05 2020-06-02 Colorado Can Llc Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
HK1244715A1 (zh) * 2015-03-02 2018-08-17 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US10028919B2 (en) * 2015-03-10 2018-07-24 Nanosphere Health Sciences, Llc Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
US10272125B2 (en) * 2015-09-14 2019-04-30 Life Tech Global, Llc Transdermal delivery of cannabidiol with other active moieties including cannabinoids
CN108697665A (zh) * 2015-09-30 2018-10-23 乔治·爱德华·霍格 局部镇痛性疼痛缓解制剂、其制备和使用方法
WO2018083695A2 (en) * 2016-11-02 2018-05-11 Tikun Olam Ltd Combination therapies
US10702495B2 (en) * 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
FR3064334B1 (fr) * 2017-03-24 2021-05-14 Dcns Energies Presse-etoupe de traversee etanche d'un orifice d'une cloison
US12357604B2 (en) * 2017-09-22 2025-07-15 Inmed Pharmaceuticals Inc. Topical formulations of cannabinoids and use thereof in the treatment of pain
EP3687527A4 (en) * 2017-09-25 2021-05-26 Canopy Health Innovations COMPOSITIONS OF CANNABIDIOL, TETRAHYDROCANNABINOL, TERPENS AND FLAVONOIDS AND THEIR USES FOR TREATMENT OF INSOMNIA
BR112020014253A2 (pt) * 2018-01-12 2020-12-08 Nutrae, LLC Formulações de canabinóides encapsuladas para administração oral
CA3112583A1 (en) * 2018-07-09 2020-01-16 New Age Nanotech Llc Stabilized formulations of cannabinoid compositions
US20210015740A1 (en) * 2019-03-04 2021-01-21 Michael Harvey Greenspan Topical cannabinoid compositions, delivery systems, and uses for pain relief
US20200360292A1 (en) * 2019-05-16 2020-11-19 Aegis Therapeutics, Llc Oil-soluble drug containing compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2023523155A5 (https=)
JP6845162B2 (ja) ケタミン経皮送達システム
CN1227012C (zh) 用于局部传送环加氧酶－2酶抑制剂的药物组合物
US20050187212A1 (en) Pharmaceutical composition for topical delivery of meloxicam
JP6259454B2 (ja) ジクロフェナク製剤
US12201622B2 (en) Continuous delivery of lenalidomide and other immunomodulatory agents
JP2022176349A (ja) ロキソプロフェン配合皮膚用外用剤
JP2022550569A5 (https=)
CN101530401A (zh) 一种用于治疗急慢性炎性疼痛的复方透皮贴片
CN1209108C (zh) 一种经皮肤传递的止吐剂成份和含相同成份的制剂
EP2491924B1 (en) Water-based paste containing diclofenac sodium
US8852628B1 (en) Transdermal drug delivery system for diclofenac
JP2026009105A (ja) ドロナビノールの経皮送達
JP2023520845A (ja) ヒドロキシクロロキン及び／又はクロロキンを含む経口送達システム
JP2024514843A5 (https=)
JPWO2009051217A1 (ja) フェンタニル含有経皮吸収製剤
JP2016014052A (ja) 含水貼付剤
JP2024514362A5 (https=)
CN113874011B (zh) 外用制剂
JP2023521563A (ja) ヒドロキシクロロキン及び／又はクロロキンを含む経皮及び／又は局所送達システム
JPWO2006080199A1 (ja) 貼付剤
JP4163859B2 (ja) 効果の高い神経弛緩剤を含有する経皮治療システム
JP5091472B2 (ja) 粘着剤及び貼付剤
WO2010098230A1 (ja) 経皮投与製剤
US20050163831A1 (en) Patch for transdermal administration